“Impact of Growth Factor Concentrate Versus Topical Steriods With Antibiotics in Type 1 Tympanoplasty”
Annals of Otology, Rhinology & Laryngology · 2026
DOI: 10.1177/00034894251362511 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Annals of Otology, Rhinology & Laryngology, 2026. Verfasst von Rashmitha Gowdlar Malleshappa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of ENT, Sri Venkateshwara ENT Institute, Bangalore Medical College and Research Institute, Karnataka, India. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Tympanic Membrane Perforation, Tympanoplasty, Otitis Media. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Background
To evaluate and compare the treatment outcomes of using topical steroids combined with antibiotics versus growth factor concentrate in type 1 tympanoplasty for chronic otitis media (mucosal type) cases. Materials and Methods: The study comprised patients with chronic otitis media mucosal type, who underwent type 1 tympanoplasty. Sixty six patients were randomly divided into 3 groups, each consisting of 33 patients. In Group A, topical steroids and antibiotics were used during the procedure, while in Group B, a growth factor concentrate was used. The outcomes were assessed through postoperative otoendoscopy and air bone gap at the end of the 1st and 3rd months.
Results
In this study, Group A (patients who underwent type 1 tympanoplasty with topical steroids and antibiotics) had a 12.1% rate of residual perforation and an 18.2% rate of reperforation after 3 months. In contrast, Group B (patients treated with growth factor concentrate) had significantly lower rates of both residual perforation (3%) and reperforation (3%). While the postoperative air-bone gap at the end of the 3rd month improved in Group B (13.58 ± 3.21 dB) compared to Group A (15.45 ± 5.11 dB), the difference was not statistically significant.
Conclusion
Growth factor concentrate has shown better graft uptake than topical antibiotics and steroids, making it a promising treatment option for augmenting tympanic membrane repair. Its biocompatibility leads to more consistent outcomes, improving patient satisfaction, and supporting broader use in otologic surgeries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of ENT, Sri Venkateshwara ENT Institute, Bangalore Medical College and Research Institute, Karnataka, India.
ORCID-Profile: Anil Kumar Ramabhadraiah
Zitieren
APA
Gowdlar Malleshappa, R., Thimmaiah, V. B., Tarikere Jayaram, R., & Ramabhadraiah, A. K. (2026). “Impact of Growth Factor Concentrate Versus Topical Steriods With Antibiotics in Type 1 Tympanoplasty”. Annals of Otology, Rhinology & Laryngology. https://doi.org/10.1177/00034894251362511
Vancouver
Gowdlar Malleshappa R, Thimmaiah VB, Tarikere Jayaram R, Ramabhadraiah AK. “Impact of Growth Factor Concentrate Versus Topical Steriods With Antibiotics in Type 1 Tympanoplasty”. Annals of Otology, Rhinology & Laryngology. 2026. doi:10.1177/00034894251362511
BibTeX
@article{GowdlarMalleshappa2026,
author = {Gowdlar Malleshappa, Rashmitha and Thimmaiah, Vidya B and Tarikere Jayaram, Roopashri and Ramabhadraiah, Anil Kumar},
title = {“Impact of Growth Factor Concentrate Versus Topical Steriods With Antibiotics in Type 1 Tympanoplasty”},
journal = {Annals of Otology, Rhinology & Laryngology},
year = {2026},
doi = {10.1177/00034894251362511}
}
EUVIMED